(Q39150753)

9 September 2017

title

Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration (English)

1 reference

9 September 2017

1 reference

Xiao-Qian Liu

1

1 reference

9 September 2017

Kang Lu

2

1 reference

9 September 2017

Li-Li Feng

3

1 reference

9 September 2017

Mei Ding

4

1 reference

9 September 2017

Jun-Ming Gao

5

1 reference

9 September 2017

Xue-Ling Ge

6

1 reference

9 September 2017

Xin Wang

7

1 reference

9 September 2017

publication date

26 June 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

55

1 reference

9 September 2017

issue

2

1 reference

9 September 2017

page(s)

405-414

1 reference

The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Tolerance, DCs and tryptophan: much ado about IDO

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

The four types of Tregs in malignant lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Mast cells are essential intermediaries in regulatory T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Regulatory T cells and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

IL-9 contributes to immunosuppression mediated by regulatory T cells and mast cells in B-cell non-hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Tryptophan catabolism and regulation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Prevention of allogeneic fetal rejection by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Modulation of tryptophan catabolism by regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Malignant B cells induce the conversion of CD4+CD25- T cells to regulatory T cells in B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.804917

10.3109/10428194.2013.804917

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference